LumiraDx to sell point of care technology platform to Roche for $295M

The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.

from MobiHealthNews https://ift.tt/97BCOdX
https://ift.tt/Mb9E0HO